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Abstract
Background: Wilson’s disease (WD) is an autosomal recessive disorder characterized by copper accumulation.
ATP7B gene mutations lead to ATP7B protein dysfunction, which in turn causes Wilson’s disease.
Case presentation: We describe a male case of Wilson’s disease diagnosed at 10 years after routine biochemical
test that showed low serum ceruloplasmin levels and Kayser–Fleischer rings in both corneas. Analysis of the ATP7B
gene revealed compound heterozygous mutations in the proband, including the reported c.3517G > A mutation
and a novel c.532_574del mutation. The c.532_574del mutation covered a 43-bp region in exon 2, and resulted in a
frameshift mutation (p.Leu178PhefsX10). By base sequence analysis, two microhomologies (TCTCA) were observed
on both deletion breakpoints in the ATP7B gene. Meanwhile, the presence of some sequence motifs associated
with DNA breakage near the deletion region promoted DNA strand break.
Conclusions: By comparison, a replication-based mechanism named fork stalling and template switching/
microhomology-mediated break-induced replication (FoSTeS/MMBIR) was used to explain the formation of this
novel deletion mutation.
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Background
Wilson’s disease (WD, OMIM #277900), an autosomal
recessive disorder characterized by abnormal copper ac-
cumulation and related toxicities, is caused by mutations
in the ATP7B gene (OMIM *606882) [1]. The ATP7B
gene is located on 13q14.3 spanning ~ 100 kb, including
21 exons and 20 introns; it encodes a transmembrane
copper-transporting P-type ATPase of 1465 amino acids,
which plays a crucial role in maintaining body copper
homeostasis and is involved in copper transport into the
plasma by ceruloplasmin as well as copper excretion
from the liver [2–4]. ATP7B gene mutations lead to
ATP7B protein dysfunction, which in turn causes accumu-
lation of copper in the liver, brain, kidneys and corneas,
with a wide range of clinical symptoms, including hepatic
disorders, neuronal degeneration of the brain, and Kayser-
Fleischer rings at the corneal limbus [5, 6]. The prevalence
of WD is estimated at 1 in 30,000, and the heterozygous
carrier rate approximates 1 in 90 in many populations
[7, 8]. Without timely diagnosis and treatment, WD can be
fatal [9]. Early detection and intervention is critical in pre-
venting disease progression and irreversible sequelae. Gen-
etic testing for the detection of biallelic ATP7B mutations
do not only help diagnose WD, but can be also used for
prenatal screening. About 540 disease-causing variants have
been reported in ATP7B according to the HUGO database,
and are mostly point mutations and small insertions or de-
letions distributed in all exons/introns (http://www.wilson
disease.med.ualberta.ca/database.asp). Screening of all
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exons and flanking intronic regions for ATP7B mutations is
usually performed by direct sequencing, e.g. Sanger sequen-
cing and next-generation high-throughput sequencing.
However, mutations are identified in only one allele
or none in a substantial number of WD patients [10].
A possible reason could be that partial gene deletions
of one or more exons are not detected by current
methods, for example c.4021 + 87_4125-2del2144, c.51
+ 384_1708-953del8798, and c.52-2671_368del3039 of
the ATP7B gene [11–13]. For unexplained WD cases,
in whom no or one allele is mutated, detecting partial
or whole gene deletions/duplications by MLPA assay,
QPCR, and other methods is required. Here we re-
port a novel 43-bp deletion by direct Sanger sequen-
cing of all exons in the ATP7B gene, which is by far
the biggest exonic deletion within a single exon of
the ATP7B gene detected in a WD patient. Mean-
while, we comprehensively analyzed the possible
mechanisms underlying the formation of this deletion
mutation, and a replication-based mechanism named
fork stalling and template switching/microhomology-
mediated break-induced replication (FoSTeS/MMBIR)
seems to explain it clearly [14–16].
Case presentation
The proband was the first child of healthy non-
consanguineous Chinese parents from Jiangsu Province.
He was born at 39 weeks of gestation, and the perinatal
period was normal. He was referred to our hospital at
the age of 10, for paroxysmal headache of an approxi-
mate one-month duration. Paroxysmal forehead pain in
this patient consisted of daily episodes at different times,
even up to dozens of times, automatically disappearing
after 1–2 min. Before the onset of these symptoms, his
developmental milestones were normal. Physical exam-
ination was normal. Neurological examination revealed
clear consciousness, normal language use, normal
muscle tone and tendon reflexes of the limbs, and nor-
mal gait. However, he presented with rapid alternating
movements of slightly clumsy hands and slightly un-
stable finger-to-nose movements. Blood routine examin-
ation for red blood cell count, white blood cell count,
platelet count, and hemoglobin was normal. Serum total
bilirubin, direct bilirubin, total bile acids albumin and
plasma ammonia levels were in control ranges, as well
as serum alanine transaminase and aspartate amino-
transferase. Normal serum total cholesterol, triglyceride,
plasma glucose and homocysteine levels were observed.
Serum creatinine and blood urea nitrogen were normal,
as well as serum electrolytes, including potassium, sodium
and chloride. Serum ceruloplasmin and copper levels were
20.6 mg/L (normal 200~ 600 mg/L) and 1.53 μmol/L
(normal 11–22 μmol/L). Kayser–Fleischer rings in both
corneas were observed under slit-lamp. Abdominal
ultrasonography showed mild spleen enlargement and
slightly increased reflectiveness of the liver and both kid-
neys, but no hepatomegaly. Cranial magnetic resonance
imaging (MRI) showed a decreased signal intensity in
T1WI and an increased signal intensity in T2WI in
bilateral caudate nucleus. The diagnosis of WD was clini-
cally made based on low serum ceruloplasmin levels and
Kayser–Fleischer rings, with the Wilson’s disease scoring
system applied as WD diagnostic criteria [17]. Improve-
ment was observed after 4 weeks of treatment with
D-penicillamine in another hospital. To further confirm
the diagnosis of WD, DNA sequence analysis of the
ATP7B gene and bioinformatics analysis were performed
by the methods in Additional file 1. The CARE guidelines
were followed in reporting this case.
Sanger direct sequencing of the 21 exons of the
ATP7B gene revealed two heterozygous mutations in
the proband: one missense variant, c.3517G > A (p.
Glu1173Lys) and one deletion variant of 43 base
pairs, c.532_574del. His mother was heterozygous for
the c.3517G > A mutation, while the father was het-
erozygous for c.532_574del (Fig. 1). Accordingly, the
proband was compound heterozygous for c.3517G > A
and c.532_574del mutations in both alleles inherited
from his mother and father, respectively. The mis-
sense mutation p.Glu1173Lys has been reported three
times in other cases (Table 1) [18–20]. The c.532_
574del mutation was predicted to cause a premature
tarnation codon (p.Leu178PhefsX10) in the N-
terminal region. According to previous reports and
the WD Mutation Database, the c.532_574del muta-
tion in our WD patient was unknown so far. Owing
to definite genetic cause of WD in our patient, the
parents was offered prenatal diagnosis during their
second pregnancy. The fetus inherited the wide-type
maternal allele and the deletion-bearing paternal al-
lele. The parents were counseled that the fetus was
predicted to be an unaffected carrier of WD.
The 193 nucleotide sequence including the 43 nu-
cleotide deletion fragment between two breakpoints
plus 75 nucleotide fragments surrounding the two
breakpoints was used for extensive bioinformatics
analysis, assessing the involvement of local genomic
architecture in the predisposition to DNA breakage, e.
g. repetitive elements, sequence motifs, and non-B
DNA conformations, which may initiate the formation
of deletions [21]. Known repeats were not found at
both breakpoints of the 193-nucleotide sequence by
the CENSOR and RepeatMasker tools. Seven se-
quence motifs previously associated with DNA break-
age, including 2 “Deletion hotspot consensus”, 2
“DNA polymerase arrest site”, 1 “Ig heavy chain class
switch repeat 1”, 1 “Ig heavy chain class switch repeat
2” and 1 “Vaccinia topoisomerase I consensus”, were
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observed in the 193-nucleotide sequence using Fuzz-
nuc. No motifs forming left-handed Z-DNA were pre-
dicted by nBMST. Direct, inverted, and mirror
repeats capable of forming slipped hairpin, cruciform,
and triplex structures, respectively, were not found in
the above sequence by RepeatAround. The QGRS
software revealed oligo(G)n tract forming tetraplex
structures in the above nucleotide sequence.
Fig. 1 Detection of a novel deletion mutation in the ATP7B in a WD patient: c.532_574del (p.Leu178Phefs*10). a The compound heterozygous
mutation was found in the proband by direct Sanger sequencing. The novel deletion mutation was inherited from his father, and the other reported
c.3517G > A (p.Glu1173Lys) mutation was inherited from his mother. The second fetus of the couple had just the heterozygous c.3517G > A mutation.
Red arrow, changed base. b The pedigree was in line with the typical Mendelian inheritance of autosomal recessive genetic diseases. Black arrow,
proband. c Illustrative explanation of the deletion mutation affecting ATP7B protein structure and composition. The 43-bp deletion results in a
frameshift mutation to produce a truncated protein with 1279 amino-acid residues deleted at the C-terminus, compared with 1465 amino-acid
residues in the normal ATP7B protein. Dashed arrows, changed position. MBDs, N-terminal metal-binding domains, including six copper binding
domains; TM1–8, eight transmembrane domains building the transmembrane channel for copper transport; A-domain, a phosphatase domain or
transduction domain where acyl-phosphate is dephosphorylated, performing ATP hydrolysis for copper cation transport; P-domain, a phosphorylation
domain for Asp phosphorylation from the DKTGT sequence; N-domain, an ATP- or nucleotide-binding domain
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Discussion and conclusions
The deletion mutation c.532_574del (p.Leu178PhefsX10)
in the ATP7B gene was reported for the first time in
present study, and was observed in proband’s parent,
was therefore not a de novo mutation. The 43-bp dele-
tion occurring in exon 2 of the ATP7B gene caused a
frameshift mutation to yield a truncated ATP7B protein,
with 1279 amino-acid residues deleted from the C-
terminal segment compared with the mature protein
consisting of 1465 amino-acid residues. The ATP7B pro-
tein includes five important functional areas that con-
tribute to copper transport, including N-terminal metal-
binding, transmembrane, adenosine triphosphate (ATP)-
binding, phosphatase, and phosphorylation domains
[22]. The deletion mutation removed almost completely
these five functional domains (Fig. 1). On the other
hand, it resulted in almost 87% amino-acid residues
missing from the entire mature protein. The variant
would be considered as a pathogenic variant with more
severe phenotype than the other missense pathogenic
variants. Indeed, the phenotype of the proband with p.
Leu178PhefsX10/p.Glu1173Lys compound heterozygote
mutations in this study was likely more severe than two
reported WD patients whose genotypes were separately
p.Pro992Leu/p.Glu1173Lys and p.Gln1200Ter/p.
Glu1173Lys (Table 1) [18–20].
After analysis of the c.532_574del mutation in the
ATP7B gene, two microhomology (DNA direct repeat
sequences, TCTCA) were observed on both deletion
breakpoints. Based on the short microhomology
stretches at breakpoint junctions, a replication-based
mechanism named fork stalling and template switch-
ing/ microhomology-mediated break-induced replica-
tion (FoSTeS/MMBIR) or a non-replicative repair
mechanism named microhomology-mediated end-
joining (MMEJ) seemed to be able to explain the for-
mation of small deletion mutations [16, 23]. However,
MMEJ associated deletions usually have imperfect or
interrupted microhomologies at the breakpoints; for
instance, distinct 8~ 22 bp pair imperfect micro-
homologies are frequently observed in the MMEJ
events of S. cerevisiae and Drosophila [10, 24–26].
Meanwhile, MMEJ occasionally generates small scars
or causes insertion of nucleotides at the junction site
of the deletion in mammalian cells [27, 28]. Indeed,
current reports suggest that microhomology is not
necessarily essential for MMEJ [28, 29]. MMEJ is cur-
rently used to explain the possible formation of large
deletions belonging to structural variations (SVs),
commonly referred to as copy number variants
(CNVs) which are generally defined as DNA regions
of approximately 50 bp and larger in size, and not
small deletions belonging to indels which are small
insertions or deletions generally between 1 and 50 bp
in size [25]. The occurrence of FoSTeS/MMBIR
events is stimulated by DNA strand breaks in the
DNA replication phase. The DNA motifs around the
deletion breakpoints would likely cause DNA strand
breaks. For example, oligo(G)n tracts have the poten-
tial to adopt stable G-quadruplex structures prone to
cause genomic alterations or replication fork stalling.
Accordingly, the FoSTeS/MMBIR mechanism seemed
Table 1 ATP7B genotypes and phenotypes of WD patients with the c.3517G > A mutation
Patient Sex Nationality Genotype* Phenotype references
Onset age
(Y)
K-F
ring
ALT
(IU/L)
AST
(IU/L)
Serum CP (mg/
L)
Serum Cu (μmol/
L)
Urine Cu
(μg/24 h)
1 M Chinese c.532_574del
(p.Leu178PhefsX10)
10 + 21 19 20 1.5 256 This study
c.3517G > A
(p.Glu1173Lys)
2 M Chinese c.2333 G > T
(p.Arg778Leu)
11 – 162 78 20 \ 532 [18]
c.3517G > A
(p.Glu1173Lys)
3 F Chinese c.2975C > T
(p.Pro992Leu)
15 + \ \ 45 \ 243 [19]
c.3517G > A
(p.Glu1173Lys)
4 \ France c.3598C > T
(p.Gln1200Ter)
33 \ \ \ 120 6.5 \ [20]
c.3517G > A
(p.Glu1173Lys)
Notes: “-”, negative; “+”, positive; “\”, unknown; “*”, compound heterozygote; F female, M male, Y years, ALT alanine aminotransferase, AST aspartate
aminotransferase, CP ceruloplasmin, Cu copper. Normal ranges are: ALT, 10~ 40 IU/L; AST, 15~ 46 IU/L; serum CP, 200~ 600 mg/L; serum Cu, 11~ 22 μmol/L; urine
Cu, 0~ 60 μg/24 h
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Fig. 2 Potential molecular mechanisms underlying the formation process of the c.532_574del mutation in the ATP7B. a Junction sequence
analysis of the 43-bp deletion identified. Five base-pairs of microhomology sequence (TCTCA) were found at both breakpoints. Sequencing re-
vealed that one FoSTeS/MMBIR event caused the deletion during two microhomologies. b The presence of sequence motifs, non-B DNA confor-
mations, or repetitive elements increased susceptibility to DNA breakage or promoted replication fork stalling. M1, deletion hotspot consensus
(TGRRKM), green underline; M2, DNA polymerase arrest site (WGGAG), dark blue underline; M3, Ig heavy chain class switch repeat 1 (GAGCT), light
blue underline; M4, Ig heavy chain class switch repeat 2 (GGGCT), orange underline; M5: Vaccinia topoisomerase I consensus (YCCTT), light green
underline; M6, oligo(G)n tracts, red underline. c Illustrative explanation of the formation process of the c.532_574del mutation in the ATP7B gene
based on FoSTeS/MMBIR mechanism during DNA replication. ① When a replication fork encounters a nick (Red hexagonal star) in a template
strand (Blue), an arm of the fork breaks off, producing a collapsed fork. ② At the double-strand end, the 5′ strand (Light blue) is resected, yielding
a 3′ overhang (Blue) with the microhomology sequence TCTCA at the terminus. ③ The 3′ single-strand end (Blue) invades the sister chromatid
(Green and Light green) in the wrong way so that the microhomology sequence TCTCA (Blue) binds to the base complementary pairing
sequence AGAGT of a single strand (Green) of the sister chromatid in the back rather than in the front, forming a D-loop. ④ New replication fork,
with both leading and lagging strand replication, was reformed. ⑤ A Holliday junction was present at the site of the D-loop. Migration of the
Holliday junction or other helicase activity, separating the extended double-strand end from its templates (Green and Light green). Finally, the
replication fork becomes fully mature and continues replication to the chromosome end, which leads to the generation of the c.532_574del
mutation. Each line represents a DNA nucleotide chain (strand). Polarity is indicated by half arrows on 3′ end
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to better explain the origin of the novel deletion mu-
tation c.532_574del of the ATP7B gene in this study.
Several mechanisms of ATP7B gene deletions have pre-
viously been reported. Alu-mediated MMEJ is a possible
mechanism underlying the formation of the 3827 bp
deletion in the ATP7B gene (c.3134_3556 + 689del) [30].
Meanwhile, Alu-mediated non-allelic homologous recom-
bination (NAHR) seems to favor the formation of the
2776 bp deletion in the ATP7B gene (c.52-2461_
366del2776) [13]. Therefore, we here report the first case
with c.532_574del of the ATP7B gene mediated by
FoSTeS/MMBIR. Since exactly 1-bp microhomology at
the junctions can cause a FoSTeS/MMBIR event, and up
to four FoSTeS/MMBIR events occur in the DNA replica-
tion phase [14–16], all reported deletion mutations of the
ATP7B gene were reviewed in Additional file 2: Table S1,
and the formation of 65.5% (91/139) small deletions as
well as 100% (4/4) gross deletions could be explained by
single template switch event in MMBIR using the
FoSTeS/MMBIR mechanism; the remaining small dele-
tions could result from two FoSTeS/MMBIR events.
Although the FoSTeS/MMBIR mechanism still is imper-
fect, it provides a perspective to explore the occurrence of
deletion mutations in the ATP7B gene.
Published studies indicated that FoSTeS/MMBIR is a
mitotic event rather than a meiotic one, e.g. somatic
mutations associated with the PMP22 and FMR1 genes
[16, 31]. Therefore, c.532_574del in the ATP7B gene
could have occurred through a single FoSTeS/MMBIR
event during the mitotic cell division of somatic cells in
grandparents or ancestors of the proband (Fig. 2).
In this study, we reported a WD patient with a novel
deletion mutation (c.532_574del43) and a known mis-
sense mutation (c.3517G > A) located in the two differ-
ent ATP7B alleles. Subsequently, genetic counseling was
provided to the proband’s family; prenatal diagnosis for
the second pregnancy of his mother was performed
using the amniotic fluid.
Additional file
Additional file 1: Materials and methods. A detailed description of the
sample acquisition, sample preparations, Sanger sequencing, alignment,
and bioinformatics analyses (DOCX 30 kb)
Additional file 2: Table S1. Overview of previously reported
pathogenic deletions of the ATP7B gene and use of the FoSTeS/MMBIR
mechanism to explain their formations (DOCX 149 kb)
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